5000th patient treated with protons for eye tumours

From the patient's perspective at the treatment station: The proton beam is directed through the hole in the shield onto the tumour in the eye. The brass shield is adjusted to the individual tumour size and protects the surrounding tissue.

From the patient's perspective at the treatment station: The proton beam is directed through the hole in the shield onto the tumour in the eye. The brass shield is adjusted to the individual tumour size and protects the surrounding tissue. © HZB/. S. Kodalle

The treatment centre for eye tumour therapy in Berlin-Wannsee

The treatment centre for eye tumour therapy in Berlin-Wannsee © HZB/ S. Kodalle

For more than 25 years, Charité – Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have been jointly offering proton radiation therapy for eye tumours. The HZB operates a proton accelerator in Berlin-Wannsee for this purpose, while Charité provides medical care for the patients. The 5000th patient was treated at the beginning of August.

The treatment room and proton accelerator are specially adapted to the requirements for optimal and highly precise treatment of tumours inside the eye and are unique in this combination. The largest group of tumours in the eye is the rare and malignant uveal melanoma, which, as the name suggests, develops in the uvea of the eye.

Proton therapy is used as an effective method of fighting tumours, often as an alternative to removing the eye, with the aim of preserving the eye and its function as much as possible. The protons can be directed very precisely at the tumour, sparing the surrounding healthy tissue. Compared to other radiation methods, proton therapy causes less damage to the cornea, lens, retina and optic nerve in many cases.

8 August 2025 was a special day: it was the day on which the 5000th patient completed their eye tumour treatment. This makes the Berlin experts one of the world's leading centres: together, the two institutions (Charité and HZB) have treated 10 percent of all eye tumours treated with protons worldwide. The cooperation with Charité – Universitätsmedizin Berlin also opens up prospects for the further development of proton therapy in order to carry out even more precise and effective treatments in the future – for the benefit of patients.

(sz)

  • Copy link

You might also be interested in

  • Perovskite triple-junction solar cells: Even more efficient with GO/SAM bilayers
    Science Highlight
    09.07.2026
    Perovskite triple-junction solar cells: Even more efficient with GO/SAM bilayers
    Perovskite semiconductors efficiently convert sunlight into electrical energy; they are also inexpensive and extremely lightweight. A team at HZB has developed a triple-junction solar cell comprising different perovskite semiconductors, with a novel bilayer of graphene oxide (GO) and a self-assembled monolayer (SAM) as the hole conductor. This bilayer significantly increases both efficiency and long-term stability. The efficiency of the novel perovskite triple-junction solar cell is 27.3% and shows hardly any decline even after more than 770 hours of operation. The study has been published in the renowned journal Joule.
  • Green Deal Ukraїna at the Ukraine Recovery Conference
    News
    09.07.2026
    Green Deal Ukraїna at the Ukraine Recovery Conference
    End of June, the Ukraine Recovery Conference (UCR2026) took place in Gdańsk, Poland. Unlike previous editions, URC2026 introduced a dedicated Energy Platform, jointly organised by the Ministry of Energy of Ukraine and the Ministry of Climate and Environment of Poland, which brought together energy-related discussions, announcements, and side events in one place, increasing the visibility and coordination of key energy topics. Green Deal Ukraїna, an initiative coordinated by HZB, organised three events on the sidelines of URC on research and energy topics as part of the conference.
  • Magnetic imaging: Micro-flowers increase the local magnetic field
    Science Highlight
    06.07.2026
    Magnetic imaging: Micro-flowers increase the local magnetic field
    Materials with magnetic nanostructures have many potential applications such as in spintronics. To explore such materials, nanoscale magnetic-sensitive imaging techniques are very useful, but up to now only weak magnetic fields could be applied during the imaging process. Now an international collaboration led by Dr. Sergio Valencia, HZB, has developed an approach that overcomes this limitation. The team designed tiny magnetic flux concentrators (MFCs), into which the sample is placed. The geometry of the MFCs resembles a flower with a number of petals which focus the applied magnetic field into its center. This greatly expands the magnetic field range available during imaging, and so the range of magnetic systems that can be investigated. The micro-flowers, enhancing magnetic fields locally, can find application in different nanometric magnetic microscopy techniques.